Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer
There has been a considerable increase in the use of ADT intensification therapies that correspond with the timing of clinical trial data and approvals of novel agents.
Authors
- Anousheh Zardan
- Devon J. Boyne (ORCID: https://orcid.org/0000-0001-6301-2429)
- Katherine Chan (ORCID: https://orcid.org/0000-0003-2356-4100)
- Steven Yip (ORCID: https://orcid.org/0000-0003-2802-6651)
- Shawn Malone (ORCID: https://orcid.org/0000-0001-5497-3455)
- Naveen S. Basappa (ORCID: https://orcid.org/0000-0002-3163-9902)
- Winson Y. Cheung (ORCID: https://orcid.org/0000-0002-3679-4290)
- Ilias Cagiannos (ORCID: https://orcid.org/0000-0002-1066-2986)
- Dylan Edmund O'Sullivan (ORCID: https://orcid.org/0000-0002-2562-0017)
- Fred Saad (ORCID: https://orcid.org/0000-0003-2986-5617)
- Sébastien J. Hotte (ORCID: https://orcid.org/0000-0001-9286-1972)
- Robert J. Hamilton (ORCID: https://orcid.org/0000-0002-6715-5934)
- Bobby Shayegan (ORCID: https://orcid.org/0000-0001-9570-610X)
- Geoffrey Gotto (ORCID: https://orcid.org/0000-0001-6637-2032)
- Christopher J. D. Wallis (ORCID: https://orcid.org/0000-0002-5990-4026)
- Ricardo Fernandes (ORCID: https://orcid.org/0000-0002-7195-8246)
- B. Osborne
- Cristiano Ferrario
- Brita Danielson
Institutions
- Western University (CA)
- Alberta Health Services (CA)
- Mount Sinai Hospital (CA)
- University Health Network (CA)
- University of Ottawa (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Juravinski Cancer Centre (CA)
- Ottawa Hospital (CA)
- London Health Sciences Centre (CA)
- Jewish General Hospital (CA)
- Princess Margaret Cancer Centre (CA)
- Centre Hospitalier de l’Université de Montréal (CA)
- McGill University (CA)
- St. Joseph’s Healthcare Hamilton (CA)
- McMaster University (CA)
Publication Details
- Journal
- Canadian Urological Association Journal
- Published
- 2024-08-30
- DOI
- https://doi.org/10.5489/cuaj.8691
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84
Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- F. Hoffmann-La Roche
- Exelixis
- Seagen
- Eisai
- Astellas Pharma
- Ipsen
- EMD Serono